Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics.

Related Keywords

,Ubiquigent Limited ,Nanna Therapeutics ,Therapeutics ,Drug Discovery ,